Work

Prenatal exposure to selective serotonin reuptake inhibitors and risk of disorders of gut-brain interaction in children

Year: 2024

Type: article

Study design: Observational Study

Source: Molecular Psychiatry

DOI: 10.1038/s41380-024-02848-3

Authors: Helene Kildegaard, Mette Bliddal, Martin Thomsen Ernst, Stine D. Sander, Rikke Wesselhoeft, Jay A. Gingrich, Anton Pottegård, Kara G. Margolis, Ardesheer Talati

Institutions: University of Southern Denmark, Odense University Hospital, Region of Southern Denmark, New York State Psychiatric Institute, Columbia University, New York University

Language: English

Topic: Pregnancy and Medication Impact

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, AstraZeneca, New York University, Novo Nordisk, Astellas Pharma, Servier, LEO Pharma, National Institutes of Health, National Institute of Mental Health, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: A multi-cohort assessment of gestational SSRI exposure on long-term psychiatric outcomes, G6234233718, Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brain, A Prospective Study Examining the Role of Gestational SSRI Exposure in the Development of Functional Gastrointestinal Disorders, Differentiating the roles and underlying mechanisms of serotonin in the gut epithelium and ENS to create a novel drug delivery system to treat disorders of gut-brain interaction and mood dysfunction

OpenAlex ID: W4405221124

FWCI: 1.884

Cites: 37

Cited by: 5

Related to: 10